clinical trial · NCT04596293
Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Bridge Biotherapeutics, Inc.·phase2·completed·n = 38
Ulcerative ColitisBBT-401-1S or Placebo
brief summary
This is a randomised, double-blind, placebo-controlled, proof of clinical principle study to explore the efficacy and safety of orally administered BBT-401-1S in subjects with ulcerative colitis.
started
Jun 11, 2021
primary completion
May 17, 2022
completion
Jul 12, 2022
last updated
Sep 7, 2023
official title
A Randomised, Double-blind, Placebo-controlled Study of Orally Administered BBT-401-1S in Subjects With Moderate to Severe Ulcerative Colitis, Incorporating a Response-adaptive, Double-blind Extension Phase
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol